LLL 44-4 : Micronutrients in acute disease and critical illness.


Journal

Clinical nutrition ESPEN
ISSN: 2405-4577
Titre abrégé: Clin Nutr ESPEN
Pays: England
ID NLM: 101654592

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 17 03 2024
revised: 12 04 2024
accepted: 15 04 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 22 5 2024
Statut: ppublish

Résumé

Micronutrients (MN), i.e. trace elements and vitamins, are essential components of the diet in relatively small amounts in any form of nutrition, with special needs in critically ill patients. Critical illness is characterised by the presence of inflammation and oxidative stress. MNs are tightly involved in antioxidant and immune defences. In addition, some conditions, and treatments result in large losses of biological fluids containing MNs: therefore, acute renal injury requiring renal replacement therapy, acute intestinal failure, and major burns and trauma are at high risk of acute depletion of body stores, and of deficiency. MN requirements are increased above standard DRI. Blood level interpretation is complicated by inflammation: some biomarkers assist the status determination. Due to the acute challenges of critical illness, it of utmost importance to cover the needs to maintain the organism's endogenous immune and antioxidant defences, and capacity to repair tissues. Practical strategies are proposed.

Identifiants

pubmed: 38777466
pii: S2405-4577(24)00104-9
doi: 10.1016/j.clnesp.2024.04.011
pii:
doi:

Substances chimiques

Micronutrients 0
Antioxidants 0
Trace Elements 0
Vitamins 0
Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-446

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the above authors declares any conflict.

Auteurs

Angélique M E de Man (AME)

Amsterdam UMC, Location Vrije Universiteit, Department of Intensive Care, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands. Electronic address: ame.deman@amsterdamumc.nl.

Karin Amrein (K)

Medical University of Graz, Department of Internal Medicine, Division of Endocrinology and Diabetology, Austria. Electronic address: karin.amrein@medunigraz.at.

Michael P Casaer (MP)

KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Intensive Care Medicine, Leuven, Belgium. Electronic address: michael.casaer@uzleuven.be.

Oguzhan S Dizdar (OS)

Department of Internal Medicine and Clinical Nutrition Unit, University of Health Sciences Kayseri City Training and Research Hospital, Kayseri, Turkey. Electronic address: oguzhansitki.dizdar@sbu.edu.tr.

Arthur R H van Zanten (ARH)

Gelderse Vallei Hospital, Ede and Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, the Netherlands. Electronic address: arhvanzanten@gmail.com.

Kursat Gundogan (K)

Division of Intensive Care Medicine, Department of Internal Medicine, Erciyes University School of Medicine, Kayseri, Turkey; North Estonia Regional Hospital, Tallinn, Estonia. Electronic address: kursatgundogan@gmail.com.

Liis Lepp (L)

Division of Intensive Care Medicine, Department of Internal Medicine, Erciyes University School of Medicine, Kayseri, Turkey. Electronic address: liis.lepp@gmail.com.

Serge Rezzi (S)

Swiss Nutrition and Health Foundation, Epalinges, Switzerland. Electronic address: serge.rezzi@nutritionhealthfoundation.ch.

Alan Shenkin (A)

Institute of Aging and Chronic Disease, University of Liverpool, Liverpool, UK. Electronic address: shenkin@liverpool.ac.uk.

Mette M Berger (MM)

Faculty of Biology & Medicine, Lausanne University, Lausanne, Switzerland. Electronic address: Mette.Berger@unil.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH